We first analyzed the RAW data of RNA-seq, which showed that drug-resistant cells had more reads mapping to exons of ACE2 than parental cells, suggesting that ACE2 may be upregulated in drug-resistant breast cancer cells (Fig. 1A). This evidence concerns the gene ACE2 and breast carcinoma.